These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 219469)

  • 21. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
    Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
    Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients.
    Brunner HR; Gavras H; Waeber B; Kershaw GR; Turini GA; Vukovich RA; McKinstry DN; Gavras I
    Ann Intern Med; 1979 Jan; 90(1):19-23. PubMed ID: 217289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin inhibitors for hypertension.
    Gavras H; Gavras I; Brunner HR
    Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term converting enzyme inhibition versus surgical treatment in hypertensive patients with renovascular disease.
    Staessen J; Bulpitt CJ; Fagard R; Lijnen P; Amery A
    Neth J Med; 1984; 27(4):161-4. PubMed ID: 6330590
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of moderate to severe hypertensive patients with an orally active converting-enzyme inhibitor.
    Prins EJ; Donker AJ; Hoorntje SJ; Leenen FH; van der Hem GK
    Proc Eur Dial Transplant Assoc; 1979; 16():603-9. PubMed ID: 232914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.
    Rubin B; Laffan RJ; Kotler DG; O'Keefe EH; Demaio DA; Goldberg ME
    J Pharmacol Exp Ther; 1978 Feb; 204(2):271-80. PubMed ID: 202692
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of specific angiotensin inhibitors in the diagnosis and treatment of arterial hypertension].
    Novikova LS; Arabidze GG
    Ter Arkh; 1979; 51(5):99-108. PubMed ID: 222004
    [No Abstract]   [Full Text] [Related]  

  • 32. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
    [No Abstract]   [Full Text] [Related]  

  • 34. Usefulness of orally active angiotensin I converting enzyme inhibitor (SQ 14,225) in the treatment of malignant hypertension.
    Abe I; Kawasaki T; Ueno M; Kawano Y; Uezono K; Ogata M; Kawazoe N; Omae T; Fukiyama K
    Fukuoka Igaku Zasshi; 1980 Mar; 71(3):157-66. PubMed ID: 6247259
    [No Abstract]   [Full Text] [Related]  

  • 35. [Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
    Lazowski J
    Wiad Lek; 1984 May; 37(10):792-6. PubMed ID: 6095537
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of inhibition of angiotensin I converting enzyme with SQ-14225 on the arterial blood pressure of mongrel dogs.
    Jandhyala BS; Washington GF; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):257-65. PubMed ID: 216064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antihypertensive effect of the oral angiotensin I-converting enzyme inhibitor in long-term treatment of hypertensive patients (author's transl)].
    Mizuno K; Gotoh M; Shigetomi S; Matsui J; Tsutsui K; Ogata M; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1113-21. PubMed ID: 7033606
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
    DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
    Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension.
    Brunner HR; Gavras H; Waeber B; Turini GA; McKinstry DN; Vukovich RA; Gavras I
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):205S-211S. PubMed ID: 223614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of bilateral renovascular hypertension controlled by angiotensin converting enzyme inhibitor (captopril) after arterioplasty for predominantly stenotic side (author's transl)].
    Sakoda H; Ohashi H; Yoshida H; Morimoto K; Kawai C; Hara A; Matsunaga M; Kawamura J; Kumada K
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):167-73. PubMed ID: 7047823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.